Evidence map›Paper›PMID 31900030›Full record

ReviewVirulence2020

Setting the stage: The initial immune response to blood-stage parasites.

Allison N Bucşan, Kim C Williamson

Open access · goldAbstract readReview
In one paragraph

Review in Virulence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Towards an evolutionary baseline model ofbioRxiv : the preprint server for biology · 2025
    Article
  4. Role of cytokines in immunomodulation during malaria clearance.Annals of medicine and surgery (2012) · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Hemozoin: a Complex Molecule with Complex Activities.Current clinical microbiology reports · 2021
    Article
  11. Frontiers in immunology · 2021
    Article
  12. Review
  13. Article
  14. Malaria and Parasitic Neglected Tropical Diseases: Potential Syndemics with COVID-19?The American journal of tropical medicine and hygiene · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Allison N BucşanDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.ORCID 0000-0002-0568-1701
Kim C WilliamsonDepartment of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.ORCID 0000-0003-2749-4082
Uniformed Services University of the Health Sciences · US

Funding

A Systems Biology Approach to Malaria ImmunityU01AI110852 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI WILLIAMSON, KIM C · 2016 to 2019
$2.8M
A Systems Biology Approach to Malaria ImmunityR01AI110852 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI WILLIAMSON, KIM C · 2015 to 2015
$778k
NIAID NIH HHS R01 AI110852NIAID NIH HHS U01 AI110852
6 · The paper itself

Abstract

Individuals growing up in malaria endemic areas gradually develop protection against clinical malaria and passive transfer experiments in humans have demonstrated that this protection is mediated in part by protective antibodies. However, neither the target antigens, specific effector mechanisms, nor the role of continual parasite exposure have been elucidated, which complicates vaccine development. Progress has been made in defining the innate signaling pathways activated by parasite components, including DNA, RNA, hemozoin, and phospholipids, which initiate the immune response and will be the focus of this review. The challenge that remains within the field is to understand the role of these early responses in the development of protective adaptive responses that clear iRBC and block merozoite invasion so that optimal vaccines and therapeutics may be produced.

Indexed as

Adaptive ImmunityAnimalsAntigens, ProtozoanAntimalarialsDendritic CellsErythrocytesHemeproteinsHumansImmunityKiller Cells, NaturalLife Cycle StagesMalariaMalaria, FalciparumMerozoitesParasitesPhospholipidsAntigens, ProtozoanAntimalarialsHemeproteinshemozoinPhospholipidsPigments, BiologicalProtozoan ProteinsProtozoan Vaccines(5–10): Malariadendritic cellsgamma-delta T cellsmonocytesNK cellsPlasmodium falciparum

Identifiers

PMID31900030
PMCPMC6961725
OpenAlexW2996896240

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.